MPPW
CRL icon

Mitchell & Pahl Private Wealth’s Charles River Laboratories CRL Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
5,523
+227
+4% +$40.4K 0.46% 74
2026
Q1 		$914K Buy
5,296
+194
+4% +$36K 0.37% 95
2025
Q4 		$1.02M Sell
5,102
-26
-0.5% -$4.72K 0.42% 87
2025
Q3 		$802K Buy
5,128
+568
+12% +$90.2K 0.34% 103
2025
Q2 		$692K Buy
4,560
+717
+19% +$95.6K 0.31% 112
2025
Q1 		$578K Buy
3,843
+240
+7% +$40.2K 0.27% 118
2024
Q4 		$665K Buy
3,603
+292
+9% +$56.2K 0.31% 107
2024
Q3 		$652K Buy
3,311
+157
+5% +$32.6K 0.3% 117
2024
Q2 		$652K Buy
3,154
+62
+2% +$14K 0.34% 104
2024
Q1 		$838K Buy
3,092
+133
+4% +$31.8K 0.44% 85
2023
Q4 		$700K Buy
2,959
+10
+0.3% +$1.97K 0.4% 95
2023
Q3 		$578K Buy
2,949
+462
+19% +$94.8K 0.34% 104
2023
Q2 		$523K Buy
2,487
+204
+9% +$40.6K 0.32% 109
2023
Q1 		$461K Buy
2,283
+52
+2% +$11.8K 0.29% 116
2022
Q4 		$486K Buy
2,231
+173
+8% +$37.8K 0.32% 109
2022
Q3 		$405K Buy
2,058
+111
+6% +$24K 0.3% 113
2022
Q2 		$417K Buy
1,947
+719
+59% +$176K 0.29% 110
2022
Q1 		$349K Buy
1,228
+175
+17% +$54K 0.22% 131
2021
Q4 		$397K Buy
1,053
+257
+32% +$99.8K 0.25% 119
2021
Q3 		$328K Buy
796
+15
+2% +$6.23K 0.24% 126
2021
Q2 		$289K Buy
+781
New +$261K 0.21% 128

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Mitchell & Pahl Private Wealth's CRL Position: Q2 2026 in Review

Mitchell & Pahl Private Wealth increased its Charles River Laboratories (CRL) stake by 4.3% in Q2 2026, buying an estimated $40.4K and bringing the position to 5,523 shares worth $1.25M. The position accounts for 0.46% of the portfolio, ranked #74.

Mitchell & Pahl Private Wealth first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. 60 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Mitchell & Pahl Private Wealth held 5,523 shares of Charles River Laboratories worth $1.25M as of Q2 2026.
  • Mitchell & Pahl Private Wealth bought 227 Charles River Laboratories shares in Q2 2026, an estimated $40.4K.
  • Charles River Laboratories made up 0.46% of Mitchell & Pahl Private Wealth's portfolio in Q2 2026, its #74 holding.
  • Mitchell & Pahl Private Wealth first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • 60 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.